The monthly series will feature a physician already utilizing Proove Genetic Testing™ who can educate peers on the advantage of having Proove Genetic Testing™ in their practices and hospitals.
Irvine, CA (PRWEB) November 16, 2015
Proove Biosciences, a commercial and research leader in Personalized Medicine, is excited to announce the launch of their Real World Evidence (RWE) Webinar series. The monthly series will feature a physician already utilizing Proove Genetic Testing™ who can educate peers on the advantage of having Proove Genetic Testing™ in their practices and hospitals.
“We’ve found that nothing is more powerful than real world evidence to support decision-making,” said Brian Meshkin, founder and CEO of Proove Biosciences. “Our expert physicians have collected data from their personal experience of using Proove’s proprietary technologies and collated it with clinical and scientific expertise to develop reliable, tried-and-true recommendations on improving patient care with Proove Genetic Testing™.”
This chapter of the webinar will feature Dr. Abraham Cherrick, of National Spine and Pain Centers, as the webinar host for the months of November 2015, December 2015, and January 2016. The webinar will focus on Dr. Cherrick’s own case studies, with empirical evidence gathered from his clinics, showing the clinical application and advantage Proove Testing can provide in a clinical care setting.
Dr. Cherrick was recognized as a principal doctor in the pain management field by Washingtonian Magazine and Northern Virginia Magazine and has a pointed interest in challenging chronic pain conditions such as fibromyalgia and CRPS. Dr. Cherrick is a founding member of National Spine and Pain Centers and serves as both a board examiner for the American Board of Physical Medicine and Rehabilitation and a Proove Medical Advisory Board member.
The Proove Biosciences’ Real World Evidence Webinars featuring Dr. Abraham Cherrick will take place on November 10th 2015, December 10th 2015, and January 11th 2016 at 1:15pm – 2:15pm eastern time. Please contact info(at)proove(dot)com for information on joining the webinar presentation.
About Proove Biosciences
Our Mission is to Change the Future of Medicine. Proove is the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could’ve ever prescribed medications without knowing how a patient would respond. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of personalized pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve outcomes – both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).